Wasatch Advisors LP 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 5:58 pm Purchase | 2022-02-11 | 13G | ARS PHARMACEUTICALS, INC SPRY | Wasatch Advisors LP | 1,775,690 5.100% | 1,775,690 (New Position) | Filing |